Pain Medicine — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Multidisciplinary subspecialty fellowship, entered mainly from Anesthesiology or PM&R (also Neurology, Psychiatry, EM).

Also called: pain management, interventional pain, chronic pain medicine. Not a residency you enter from medical school, but a 1-year fellowship after one of several base residencies. Organ system: the nervous system and the musculoskeletal system, the machinery of pain from spine to peripheral nerve.

The 30-second version

Pain Medicine is the field organized around a symptom instead of an organ, the diagnosis and treatment of chronic pain, mostly in an outpatient clinic, increasingly with your hands. You evaluate people whose pain has outlasted its original cause, build a treatment plan, and then, on procedure days, do image-guided interventional work: epidural steroid injections, nerve blocks, radiofrequency ablation, and increasingly neuromodulation (implanting spinal cord stimulators and drug pumps). What makes it distinctive is the shape of the life as much as what you do. For many who reach it through anesthesiology, pain is explicitly an escape hatch from the OR, the 6 a.m. starts, and overnight call, in favor of a daytime, mostly-elective, strong-paying clinic-plus-procedures career. The honest trade: the patient population is genuinely hard, and the opioid/regulatory environment is a real, career-shaping stressor no other outpatient field carries the same way.¹²

Quick dashboard (details and sources below)


Training after med school	base residency (3–4 yrs) + Pain Medicine fellowship (1 yr)
Total from college start	~12–13 years (4 undergrad + 4 med school + 3–4 base residency + 1 fellowship) — 13 by the two dominant routes, since anesthesiology and PM&R are both four years
Competitiveness	Moderate — and softening: ~82% of fellowship spots filled in 2025 ⟳
Typical full-time pay	~$450,000–$650,000 total comp (interventional); higher with ASC ownership ⟳
Pay range (structure)	Cognitive/employed ~$300k–$435k · interventional median ~$630k · top-decile owners $900k–$1.2M ⟳
Lifestyle	Outpatient, mostly daytime, minimal-to-no overnight call — but there's a clinic and an inbox
Burnout	Not broken out in big surveys. Of 275 ASA and ASPN members surveyed in 2021, 74.9% would choose it again, in a study whose authors conclude poor job satisfaction is widespread ⟳
% women	~21% of recent fellowship applicants — low, and falling ⟳
DO / IMG accessibility	Relatively open (~32% DO, ~15% IMG of matched fellows) ⟳

What they actually do

Pain physicians manage chronic pain, meaning pain that has persisted past healing, often from the spine, joints, nerves, or cancer, plus some acute and post-surgical pain. The work splits into two rhythms. Clinic days are cognitive: histories, physical exams, imaging review, medication management, and building a plan for people whose pain is complex and often improvement-resistant. Procedure days are interventional: image-guided injections and ablations in a fluoroscopy suite or ambulatory surgery center (ASC). The modern field has shifted decisively away from chronic-opioid prescribing toward procedures and multimodal care, partly because it works and partly because of the regulatory climate (below).¹³

The center of gravity is increasingly interventional and device-based. Beyond injections, pain physicians implant spinal cord stimulators, dorsal root ganglion and peripheral nerve stimulators, and intrathecal drug pumps, making this a surprisingly technology-heavy, craft-driven specialty. Unlike the anesthesiology base many come from, pain has continuity: you follow patients over months and years, which brings relationships, but also a clinic, an inbox, prior authorizations, and documentation.¹²

Representative procedures: epidural steroid injections · facet joint / medial branch blocks · radiofrequency ablation (RFA) · sympathetic and peripheral nerve blocks · joint injections · spinal cord stimulator / DRG / peripheral nerve stimulator implantation · intrathecal pump placement · kyphoplasty/vertebral augmentation · diagnostic nerve blocks. ResidencyAdvisor puts a heavy procedure day at roughly 18–35 injections for an interventional proceduralist.²

A week in the life: You alternate or blend clinic and procedures. A clinic day is a full template of evaluations and follow-ups: new referrals with failed back surgery, neuropathy, or cancer pain; established patients you're titrating or planning procedures for. A block day is spent under fluoroscopy running through a scheduled list of injections and ablations, or in the ASC placing a stimulator. Most jobs are weekday, daytime, with little or no in-house call and few true emergencies, so the schedule is largely yours to template. What follows you home is the portal messages, refill requests, and prior-auth paperwork of an outpatient panel rather than a pager.¹²

The training path & time to completion

Medical school (4 yrs) → a base residency (3–4 yrs) → 1-year ACGME Pain Medicine fellowship → subspecialty certificate through your base board. This is the field's defining structural feature: it's a multidisciplinary fellowship co-sponsored by four ABMS boards, so physicians from several different residencies can enter it and certify in it.⁴⁵

The base residency is the big fork. Pain is officially a subspecialty of anesthesiology, PM&R, neurology, and psychiatry, and ACGME permits a resident from any specialty meeting its requirements to enroll in a pain program, on the reasoning that physicians in many specialties benefit from the training. ACGME also warns in the same breath that enrolling and certifying are separate questions: not every certifying board recognizes pain subspecialty education, and the fellow and the program director are the ones responsible for settling board eligibility with that board before enrollment.⁴ In practice anesthesiology and PM&R dominate: anesthesia has historically supplied the plurality of fellows (its procedural, needle-based culture translates directly), with PM&R a strong second (musculoskeletal and interventional emphasis). Neurology, psychiatry, EM, and FM are recognized but smaller feeders.⁴⁶
The base you come from shapes the career. Anesthesia- and PM&R-trained physicians tend to run more interventional practices; neurology-, psychiatry-, and FM-trained physicians more often run clinic-heavy, medication-management practices, and that interventional-vs-medical split is the single biggest driver of both lifestyle and income (see Compensation).⁶³ It also means there's more than one road in: PM&R, in particular, is generally less competitive to match than anesthesiology, giving a realistic alternate route to the same procedural-lifestyle field.¹
Fellowship length: 12 months, and in ACGME's own words a requirement rather than a norm: "The educational program in pain medicine must be 12 months in length," tagged Core, which means mandatory. The 50-page document contains no 24-month option.⁴⁷
Board: a subspecialty certificate awarded through your primary board: ABA (anesthesiology), ABPMR (PM&R), ABPN (neurology/psychiatry), or ABEM (emergency medicine, approved in 2014). There is no standalone "pain board." (FM graduates may train, but their certification route is less clearly documented; verify.)⁴⁵ ⟳
Total from the start of college: ~12–13 years (4 undergrad + 4 med school + 3–4 base residency + 1 fellowship). Anesthesiology and PM&R, the two feeders most people come through, are four-year residencies, so 13 is the realistic number to plan around.

How competitive is it?

Pain Medicine is moderately competitive, and softening. It matches through the NRMP Specialties Matching Service (SMS), and the recent trend is exactly the kind of hidden context a premed would never pick up from a list.

In the 2026 appointment year: 112 programs, 390 positions offered and 333 filled, an 85.4% fill rate, with 28 programs left short.⁸ With more positions (390) than applicants (355), the field overall is not statistically hard to enter right now, though the well-regarded academic and interventional programs stay competitive.⁸

What that means for you today:

The fill rate held for three cycles, fell in one, and has been flat since: 96.6% (2021), 95.8% (2022), 95.0% (2023), then a 10.5-point drop to 84.5% (2024), 82.3% (2025) and back up to 85.4% (2026). The shape matters more than the endpoints, because a single-cycle cliff points at a single cause and a slow slide does not: the cause named in the literature is a collapse in anesthesiology-resident applications.⁸⁹ ⟳
A dedicated study documented the pullback: anesthesiology-resident applications to pain fellowships fell 45% between 2019 and 2023, from 351 to 193, the steepest drop of any feeder specialty; the 2023 match left 35 of 115 programs with unfilled spots.⁹ ⟳
The entering class is relatively open to DO and IMG applicants: among matched fellows, roughly 32% DO and ~15% IMG, a higher share than many subspecialties.⁸ ⟳

The honest read: the door to a pain fellowship is more open than it was five years ago (especially from PM&R and for DO/IMG applicants), but the softening partly reflects a base-specialty pipeline (anesthesiology) in flux, so weigh the fellowship's accessibility together with the realities of whichever base residency you'd enter through.

Compensation — the robust version

Pain pay is strong but unusually source-dependent and spread out, because so much of it is driven by interventional-vs-medical practice, ownership, and procedure volume rather than seniority. A note on sources first: pain is a small subspecialty, and the big national surveys (Doximity, Medscape) mostly fold it into "Anesthesiology" rather than breaking it out. The pain-specific figures come from smaller self-reported databases (Physician Side Gigs, and SalaryDr's panel of 26), which are directional rather than authoritative, while job-board and aggregator sites (Salary.com, ZipRecruiter) capture mostly base cash and skew low. Treat the ranges as ranges.³¹⁰¹¹

National number. Depending on source and definition, pain lands anywhere from ~$330,000–$400,000 (job-board/aggregator, mostly base) to ~$457,000 (Physician Side Gigs full-time avg) up to ~$630,000–$640,000 (SalaryDr median/avg, small n). A defensible "typical full-time" figure for an interventional pain physician sits roughly in the mid-$400Ks to ~$650K total comp; cognitive/medical practices track nearer $300K–$400K.³¹⁰¹¹ ⟳

The spread (structure). SalaryDr's 2026 percentile set (small n, verify): 10th $420k · 25th $465k · median $630k · 75th $800k · 90th $900k, with a reported range up to ~$1,000,000 and a median bonus of $150k (92% receive incentive pay). Physician Side Gigs shows a full spread of $180k–$1,200,000 (median $414k). The takeaway: a floor around $180k–$300k (part-time / low-volume / cognitive) up to $900k–$1.2M for top-decile high-volume interventionalists and owners.³¹⁰ ⟳

Seniority matters, but practice model and ownership matter more. SalaryDr shows early-career (0–5 yr) ~$530k rising to ~~$750k at 10+ yr (~~+42%, small n). But the bigger lever is ownership: owners/partners ~$571k vs. W-2 employed ~$435k (~31% higher for owners). The top earning model is private interventional practice with ASC or office-procedure ownership, where you capture the facility/technical fee (not just the professional fee) plus device margins on neuromodulation implants, the route multiple sources cite for $1M+ mature comp.³¹⁰ ⟳

Interventional far outpaces medical and cognitive practice, the field's defining pay axis. Procedures (epidurals, facet/medial-branch blocks, RFA, kyphoplasty, and especially spinal cord stimulator/neuromodulation implants) generate far higher RVUs and facility revenue than E/M and medication-management visits. A cognitive-only practice tracks nearer the low-$300Ks–$400Ks; a high-volume interventional/neuromodulation practice can double that or more.³

Base specialty shapes income, but less than you'd think at equal volume. Physician Side Gigs (2024): anesthesiology-trained pain ~$488k vs. non-anesthesiology (mainly PM&R) ~$407k, about 20% higher, driven by anesthesia's procedural-throughput culture and easier ASC positioning. But at equal procedural volume, the anesthesia-vs-PM&R median gap is modest, and earnings are driven more by fellowship quality, first-job structure, and ASC access than by which residency you came from. Neurology/psychiatry/FM-trained physicians, running more clinic-heavy practices, sit at the lower end unless they build procedural volume.⁶³

Setting & geography.

By setting (Physician Side Gigs 2024): hospital-employed ~$501k · group private practice ~$466k · government/military ~$301k; academic ≈ ~13% lower than private (fewer hours, no procedural bonuses).³¹¹ ⟳
Geography: Midwest/South/rural markets tend to pay the highest guaranteed comp (supply–demand); desirable coastal metros offer lower base pay and higher competition. No published dataset measures pain-medicine pay by metro, so treat that direction as the shape of the market rather than as a measurement. Actual earnings track ASC access and payer mix more than state lines.³ ⟳

Anchor to the base specialty. Because surveys fold pain into anesthesiology, the base-specialty numbers are a useful backstop: Anesthesiology ~$523k (Doximity 2025) to ~$543k (Medscape 2026); PM&R ~$375k (Doximity 2025). Medical-leaning PM&R pain tracks nearer the latter, interventional pain well above it.¹¹ ⟳

The trend that colors all of it. Pain comp has grown steadily (~+6% in 2024). The opioid-regulation climate (CDC guidelines, DEA/state PDMP enforcement, prescribing limits) has pushed the field decisively away from chronic opioid management toward interventional procedures, reinforcing the interventional premium and the value of procedural/ASC skills. Neuromodulation volume (SCS/DRG/peripheral stimulators, RFA) is the main upside driver, high-margin and favorably reimbursed, though prior-authorization hurdles and professional-fee reimbursement pressure are headwinds; the durable margin sits in facility-fee/ASC capture.³¹² ⟳

Lifestyle & the outpatient bargain

The single most-cited pro of pain medicine: minimal-to-no overnight call and a predictable, mostly-daytime outpatient schedule. For an anesthesiologist tired of 6 a.m. starts, OB nights, and trauma call, this is the entire point: you keep the needle skills and hands-on procedural craft but trade the OR for a clinic-and-procedure life you largely template yourself. The PM&R route in particular is associated with the best odds of no call and strong work-life balance at similar earnings.¹²

The single most-cited con, and it's the same coin: you pick up a clinic and an inbox. Unlike pure anesthesiology, pain has continuity: portal messages, refill requests, prior authorizations, denials, and documentation follow an outpatient panel. It trades the OR's clean "leave it at the hospital" boundary for outpatient administrative load. And the patient population itself is a lifestyle factor: chronic, often non-improving pain is emotionally heavier work than a procedure list suggests (see Wellbeing).¹²

Lifestyle rating: 4/5. High schedule control and little-to-no overnight call (a genuine step up from the anesthesiology base), tempered by outpatient inbox load and an emotionally demanding panel.

Wellbeing — the part to take seriously

Burnout is not cleanly measured, so be skeptical of any "pain = X%" claim. Pain medicine is usually folded into anesthesiology or PM&R in the big Medscape rankings, so field-specific burnout percentages mostly don't exist. For general 2025 context, overall physician burnout has drifted down to roughly 42% (AMA).¹³ The best pain-specific evidence is a dedicated survey rather than a national ranking.¹⁴ ⟳

Would-choose-again is high, and the same study's satisfaction scores are not. Job Satisfaction Among Pain Medicine Physicians in the US (Journal of Pain Research, 2023) emailed a questionnaire in 2021 to pain physicians who belonged to the American Society of Anesthesiologists or the American Society of Pain and Neuroscience. 275 of them answered, 81.8% of those anesthesiologists and 13.8% physiatrists. Of those respondents, 74.9% said they would choose pain medicine again, the median score for recommending it as a career was 8.0/10, and median income satisfaction was 7.0/10. The authors' own conclusion is that high rates of poor job satisfaction persist in the field. Both readings come out of one survey, and the gap between them says more than either half.¹⁴ ⟳

Where the dissatisfaction clusters. The same study found lower satisfaction / higher burnout among women (less practice control, higher burnout than men), physicians in the Northeast (lower income satisfaction), and those with heavily Medicare payer mixes. Solo and private-practice partners reported the most autonomy and job security; employed and early-career physicians reported more burnout. Practice model, geography, and payer mix shape the experience more than the specialty label does.¹⁴

The two defining stressors are regulation and the patient population. These are what make pain's wellbeing story distinctive, and they're covered honestly in the culture section below. The short version: opioid/DEA/medical-board scrutiny is a real, career-shaping pressure unique in its intensity, and a chronic, often improvement-resistant, sometimes secondary-gain-complicated patient panel carries a heavy emotional load.¹⁵¹⁶¹⁷

Career longevity is a quiet strength. Physically far less demanding than surgery, with no vigilance-heavy overnight call and a schedule that ages well. Tellingly, many anesthesiologists move into pain later in their careers specifically to shed OR call. Pain is often the destination people move toward rather than the field they flee.¹

Who's in the field (demographics)

Women: roughly 21% of recent fellowship applicants (2023), which is low and falling (down from ~25% in 2019; female applications dropped ~28% over five years). Historically women were ~17–21% of pain fellows across 2009–2019. Pain is one of the less gender-balanced fields, and the gap is widening rather than closing.⁹¹⁸ ⟳
DO: 32.1% of matched fellows, relatively DO-friendly versus many subspecialties.⁸ ⟳
IMG: ~15% of matched fellows (US-citizen plus non-US-citizen IMGs), a meaningful entry point.⁸ ⟳
Race/ethnicity (URiM): racial minorities are underrepresented. In the 2009–2019 cohort, Asian, Black, and Native American/Alaska Native physicians had significantly lower odds of being pain fellows than White peers; White applicants fell modestly from 43% (2019) to 40% (2023). A clean current URiM percentage isn't published for 2025 (limited data).¹⁸⁹ ⟳

Culture, personality & the online stereotypes

Who gravitates here: proceduralists who want to keep hands-on interventional work but escape the OR and call for a clinic-plus-procedures lifestyle. The classic path is an anesthesiologist who loves using their hands but is done with 6 a.m. starts and overnight OB/trauma; people drawn to interventional and neuromodulation craft (image-guided injections, ablations, implanting stimulators and pumps); PM&R physicians who want a higher-procedure, higher-earning musculoskeletal niche with excellent work-life balance; and people comfortable with ambiguity and continuity, meaning chronic conditions, long relationships, and no clean cures, who still want a procedural component. As always, plenty of people in the field do not fit any single mold.²

The online reputation (candid, attributed community perception rather than fact, each with a fair counterpoint):

"A great-lifestyle, great-money escape hatch from anesthesia." The read online. The kernel of truth: for anesthesiologists, pain genuinely trades call and early starts for a daytime clinic-and-procedure life at strong pay. Counterpoint: it's not a free lunch, because you pick up a clinic, an inbox, a genuinely difficult patient population, and a regulatory microscope the OR never had. Different hard, not easy.²
"Opioid/DEA scrutiny, difficult patients, and secondary-gain frustration." A common community perception, and the reason some avoid the field. Counterpoint: modern pain medicine is far more interventional and multimodal than opioid-centric, many practices deliberately minimize chronic-opioid prescribing, and satisfaction tracks the practice model closely. Three-quarters would choose the field again even in the survey that reports widespread poor job satisfaction.²¹⁴
"The interventional 'pill mill.'" A stereotype, and one most pain doctors actively resent. A tiny number of bad actors created a caricature that tars an entire legitimate, board-certified field. Counterpoint: the overwhelming majority are careful, ethical clinicians who feel unfairly stigmatized by both the caricature and the regulatory backlash it triggered.²
"The private-practice interventional gold rush." The read online. There's truth in the earning ceiling, since ASC ownership and procedure volume can push income high. Counterpoint: it takes business risk, a favorable payer mix, and volume; hospital-employed and Medicare-heavy practices earn far less, and the money framing undersells how demanding the patient work is.²

These are reputations and community reads rather than verdicts on real people, and plenty of pain physicians fit none of them.

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums, pain is the go-to exit from OR call, with attractive lifestyle and pay, but posters warn the patient population and the opioid/regulatory climate are the real catch, and that not everyone enjoys clinic and continuity after training for the OR. Among physiatrists, pain is framed as the high-earning, high-procedure endpoint of PM&R, prized for autonomy and lifestyle; debate centers on fellowship competitiveness, procedural-training quality, and interventional-heavy vs. balanced practice. In broader physician and trainee discussion, sentiment is more candid: respect for the interventional skill and lifestyle, but recurring frustration about DEA/board risk, insurance denials and prior auths, difficult or secondary-gain patients, and the lingering "pill mill" stigma. The through-line: the practice model and payer mix determine whether the job feels great or grinding, so choose your first job carefully.¹⁹

Voices from the field. Paraphrased from public writing, with links to the originals:

Maloney et al. in the Journal of Pain Research surveyed 275 ASA and ASPN members in 2021, concluded that high rates of poor job satisfaction persist in the field, and found the dissatisfaction concentrated among women, Northeast practitioners, and Medicare-heavy and employed physicians, evidence that practice conditions rather than the specialty itself drive the misery. Three-quarters of the same respondents said they would choose pain medicine again.¹⁴
A physiatrist and pain physician on KevinMD argues medical boards have swung from protecting patients to punishing pain doctors, documenting heavy financial and psychological costs (including a roughly 3.2-fold increased burnout risk among targeted physicians) and a chilling effect that leaves legitimate pain undertreated.¹⁵
A surgeon and a chemist writing on KevinMD contend that opioid "pain contracts," with their drug testing, behavioral rules, and threat of discharge, turn physicians into enforcement officers, uniquely stigmatize pain patients, and erode trust, with little evidence they reduce harm.¹⁶
A physician on Doximity Op-Med reflects candidly on decades of unfair bias against chronic-pain and substance-use patients and how education changed his approach, a window into the stigma these patients, and the doctors who commit to them, navigate.¹⁷

Why people choose it / why people leave

Why choose it: minimal-to-no overnight call and a predictable, mostly-daytime outpatient schedule · procedural craft plus continuity (you keep injections, ablations, and neuromodulation and follow patients over time) · strong, procedure-driven pay with a high ceiling via ASC ownership · a career that ages well, being physically undemanding with no vigilance-heavy nights · reachable from several residencies, including the more accessible PM&R route · a technology- and device-heavy field with real craft.

Why leave or avoid it: opioid, DEA, and medical-board scrutiny, a real and career-shaping regulatory risk unique in its intensity · a genuinely hard patient population of chronic, often non-improving pain with a subset of opioid-seeking or secondary-gain dynamics, and high emotional load · you do get a clinic and an inbox (prior auths, denials, refills, documentation) · the lingering "pill mill" stigma that unfairly colors public and even peer perception · income and satisfaction that depend heavily on practice model, geography, and payer mix, not just the credential · an extra fellowship year before attending income.

Best fit if: you want procedural, hands-on medicine and long-term patient relationships · you'd trade the OR and overnight call for a daytime clinic-and-procedure life · you can stay steady, compassionate, and ethical under regulatory pressure and with challenging patients · you're drawn to interventional/neuromodulation craft and the technology behind it.

Not for you if: you want a clean no-inbox/no-continuity boundary · you dislike managing chronic conditions that don't fully resolve · you'd find opioid/DEA/board scrutiny corrosive · you have low tolerance for difficult or secondary-gain patient dynamics · you need to reach an attending income without an extra training year.

The FLI angle — Pain Medicine for first-gen, low-income & immigrant students

Where pain medicine fits FLI realities well:

High pay plus a good lifestyle, a rare and powerful combination. Strong income (often $400–700K+, higher with ownership) with minimal call and a predictable daytime schedule is unusual in medicine and financially powerful for someone paying down loans and supporting family.¹²
An escape from the base specialty's call. You enter through a residency and then fellowship into a life with little overnight work, protecting time for caregiving and family obligations common among FLI students. Pain is the field people move toward to shed call, not away from.¹
More than one road in, including an accessible one. It's reachable via PM&R, generally less competitive to match than anesthesiology, a realistic alternate pathway to the same high-paying procedural-lifestyle field. And the fellowship itself is relatively open to DO and IMG applicants (~32% DO, ~15% IMG of matched fellows).¹⁸
Portable, in-demand procedural skills. Interventional skills travel, including to higher-paying non-coastal markets near family.³

Risks to name honestly:

Opioid/DEA/medical-board scrutiny is the standout risk. Investigations carry real financial and career danger, and the burden of navigating regulation falls hardest on those without resources or legal support.¹⁵¹⁶
Difficult-patient burnout is real. The chronic, stigmatized, sometimes secondary-gain patient population is emotionally taxing and can wear on people over time.¹⁷
You add a clinic and an inbox. More administrative load than pure anesthesiology.²
The highest incomes require business risk. ASC ownership may be less accessible without capital or connections; employed, Medicare-heavy roles earn substantially less.³
It requires a fellowship. An extra training year beyond a residency, a real consideration if you need to reach an attending income quickly.⁴

Bottom line: Pain medicine is one of the clearest routes in medicine to high pay and a controllable, mostly-daytime outpatient life, reachable through several residencies, including the accessible PM&R route, and relatively open to DO and IMG applicants. But that upside comes bundled with a regulatory microscope no other outpatient field carries the same way, a genuinely hard patient population, and incomes that swing hard on practice model and ownership. Shadow a real clinic and a procedure day before you commit, because the two halves feel like different jobs.

Subspecialties, flavors & practice models

Pain is itself a subspecialty, so the meaningful "sub-flavors" are about how you practice rather than further boards:

Interventional pain. Procedure-heavy: injections, RFA, and neuromodulation implants, often in an ASC or office-based lab; the highest-earning model.³
Medical / cognitive pain. Evaluation, multimodal and medication management, minimal procedures; more common among neurology-, psychiatry-, and FM-trained physicians; lower-earning but clinic-focused.³
Neuromodulation-focused practice. Spinal cord stimulators, DRG and peripheral nerve stimulators, intrathecal pumps; the device- and technology-heavy leading edge of the field.¹
Cancer / palliative-leaning pain. Complex cancer pain, intrathecal therapy, often alongside palliative care.
By practice setting: hospital/health-system employment (stable base + RVU/procedure incentives) · private single- or multi-specialty group (partnership → ownership) · physician-owned interventional practice with ASC/office procedures (highest ceiling, most business risk) · academic (lowest cash, protected time/teaching).³

Fun facts

Pain medicine is one of the few fellowships you can reach from many different residencies (anesthesiology, PM&R, neurology, psychiatry, EM, and family medicine), a rare "many roads in" subspecialty.
It's a co-sponsored ABMS certificate: four boards (ABA, ABPMR, ABPN, ABEM) award the subspecialty certificate through a physician's primary board rather than a standalone pain board.
For anesthesiologists, it's a well-known late-career off-ramp from OR call, and pain is frequently the destination people move toward rather than away from.
Modern practice is increasingly about neuromodulation, implanting spinal cord stimulators and drug pumps, which makes it a surprisingly device- and technology-heavy field.
It's one of the most regulated prescribing environments in medicine, with pain "contracts" and drug testing that are nearly unheard-of in other specialties.
74.9% of the 275 pain physicians who answered a 2021 society survey said they'd choose the field again — the same survey whose authors conclude that poor job satisfaction is widespread in the specialty.¹⁴
The earning ceiling is unusually elevated by business ownership, and ASC equity rather than clinical volume alone is a big lever on income.

Sources

Lifestyle, base-specialty routes, escape-from-OR framing, PM&R accessibility, and career longevity. ResidencyAdvisor, "Pain Management Pathways: Anesthesia vs PM&R vs Neurology — Earnings" (2025) — https://residencyadvisor.com/resources/highest-paid-specialties/pain-management-pathways-anesthesia-vs-pmr-vs-neurology-earnings; painmed.org, "Paths Into Pain Medicine" — https://painmed.org/voices-in-pain-medicine-established-pathways-to-pain-med/. Corrected 2026-08-17: this footnote supports lifestyle, route and longevity claims, none of which quotes a figure, so nothing needed surfacing into the body. Worth flagging for whoever edits the FLI section next: its "$400–700K+" band cites this footnote and ² alongside the lifestyle half of the sentence, but the band restates the Compensation section, which rests on Physician Side Gigs and SalaryDr at ³ and ¹⁰. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹²
Day-to-day, procedure volume, clinic-plus-inbox reality, and the online reputation/counterpoints. ResidencyAdvisor (2025) — https://residencyadvisor.com/resources/highest-paid-specialties/pain-management-pathways-anesthesia-vs-pmr-vs-neurology-earnings; synthesized community sentiment (see ¹⁹). Corrected 2026-08-17: ResidencyAdvisor is now named in the visible sentence for the 18–35 injections figure, the one number on this page that rests on it. Everything else this footnote supports is qualitative — the day-to-day rhythm, the clinic-plus-inbox reality, the stereotypes and their counterpoints — and quotes no figure. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴
Compensation structure — interventional vs. cognitive, ownership/ASC lever, setting, geography, base-specialty gap, and trends. Physician Side Gigs — Pain Management salary (2024) — https://www.physiciansidegigs.com/average-pain-management-physician-salary; Physicians Thrive — Pain Management Salaries — https://physiciansthrive.com/physician-compensation/pain-management-salary/. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵ ↩¹⁶ ↩¹⁷
Multidisciplinary entry routes, eligible base specialties, fellowship length, and co-sponsoring boards. Section 4.1, Length of Program: "The educational program in pain medicine must be 12 months in length. (Core)" — a Core requirement is mandatory. Corrected 2026-08-17: this page described 12 months as "the standard ACGME pathway" with "a minority of programs offer an optional 24-month track (clinical + research)." The strings "24 month", "24-month" and "two year" appear nowhere in the 50-page document, and the standard/optional framing told a reader a two-year route existed to choose. Institutions do sometimes add a research year to a fellowship, but that is an institutional arrangement rather than the ACGME pain medicine program this bullet describes, and no institution is cited for it here. ACGME, Program Requirements for Graduate Medical Education in Pain Medicine (2025) — https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/530_painmedicine_2025_reformatted.pdf; ABMS, Specialty and Subspecialty Certificates — https://www.abms.org/member-boards/specialty-subspecialty-certificates/. (Previously cited to the EMRA Fellowship Guide, which has been retired.) Corrected 2026-08-17: the base-residency bullet carried "no specialty is barred" inside quotation marks. The word "barred" does not appear anywhere in the 50-page requirements document. What it says, in its Subspecialty-Specific Background and Intent under 3.2.a.1, is that "the ACGME permits a resident from any specialty that has met the requirements below to enroll in a pain program," immediately followed by the warning that "not every certifying board will recognize pain subspecialty education" and that the fellow and program director must settle board eligibility before enrolling. The substance held and the quotation marks did not; the bullet now paraphrases ACGME and carries the caveat, which the page had been dropping. The likely origin of the string is the retired EMRA guide this citation replaced. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
Subspecialty certification through the primary board (ABA, ABPMR, ABPN, ABEM 2014). ABPMR — Pain Medicine — https://www.abpmr.org/Subspecialties/Pain; ABPN — Pain Medicine exam — https://abpn.org/become-certified/taking-a-subspecialty-exam/pain-medicine/. ↩ ↩²
Anesthesiology and PM&R as the two dominant feeders; base-specialty influence on interventional-vs-medical practice and income. Physician Side Gigs — Pain Management salary (2024) — https://www.physiciansidegigs.com/average-pain-management-physician-salary; ResidencyAdvisor (2025) — https://residencyadvisor.com/resources/highest-paid-specialties/pain-management-pathways-anesthesia-vs-pmr-vs-neurology-earnings. Corrected 2026-08-17: the two dollar figures in the base-specialty paragraph are Physician Side Gigs', already named there. ResidencyAdvisor supports the feeder-specialty and interventional-vs-medical claims here, neither of which carries a number, so nothing needed surfacing. ↩ ↩² ↩³
ACGME Program Requirements for GME in Pain Medicine (revised 2025) — https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/530_painmedicine_2025_reformatted.pdf. ↩
NRMP, Results and Data: Specialties Matching Service, 2026 Appointment Year (Feb 2026), Tables 1A and 2 — Pain Medicine: 112 programs, 390 positions offered, 333 filled (85.4%), 355 applicants, 28 programs left unfilled. Of the 333 matched, US MD 52.0%, US DO 32.1%, US IMG 9.0%, non-US IMG 6.6%. https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf. Prior cycle: 111 programs, 389 positions, 320 filled (82.3%). The five-year fill-rate trend table in the same report gives 85.4% (2026), 82.3% (2025), 84.5% (2024), 95.0% (2023) and 95.8% (2022) on 390, 389, 393, 377 and 378 positions; the 2021 figure of 96.6% on 349 positions comes from the equivalent table in the 2025 edition, https://www.nrmp.org/wp-content/uploads/2025/02/SMS_Results_and_Data_2025.pdf. Corrected 2026-08-17: this page said the fill rate "fell for five cycles, then turned," quoting the 2021 and 2025 endpoints. The series between them is flat for three cycles and then drops 10.5 points in one, from 95.0% to 84.5%, and it did not fall at all across 2024 to 2026. Corrected 2026-08-17: the DO share was rounded to "roughly 30%" in four places, including the Quick dashboard, while this footnote already carried NRMP's exact 32.1%. The rounding ran two points against the page's own accessibility argument. All four now say 32%. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷
Fill-rate decline (~96.6% 2021 → 82.3% 2025) and falling application volume, especially from anesthesiology; women applicant share falling. Pritzlaff et al., "Declining pain medicine fellowship applications from 2019 to 2024," Pain Practice (2025), PMID 39548886 — https://pubmed.ncbi.nlm.nih.gov/39548886/; news-medical.net summary (2025) — https://www.news-medical.net/news/20250128/Fewer-anesthesiology-residents-applying-to-US-pain-medicine-fellowships.aspx. Corrected 2026-08-17: this page had the paper's two percentages the wrong way round, assigning the 45% decline to the whole applicant pool and inventing a separate ~14% for anesthesiology residents that the paper does not contain. The abstract gives one figure: anesthesiology-resident applications fell from 351 in 2019 to 193 in 2023, a 45% decline the authors call "the highest detriment among anesthesiology applicants compared to other specialties." The swapped version also contradicted the sentence above it, which correctly attributes the fill-rate slide to the anesthesiology pipeline. ↩ ↩² ↩³ ↩⁴
Percentile spreads and self-reported total-comp figures (small n — verify). SalaryDr — Pain Management (updated Jul 2026) — https://www.salarydr.com/specialty/pain-management; Salary.com — Interventional Pain Medicine Physician (2026) — https://www.salary.com/research/salary/alternate/interventional-pain-medicine-physician-salary; ZipRecruiter — Interventional Pain Management Physician (2026) — https://www.ziprecruiter.com/Salaries/Interventional-Pain-Management-Physician-Salary. SalaryDr panel size: n=26. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. On Salary.com: its CompAnalyst benchmark is HR-reported employer survey data blended with job-posting data, not a physician panel. It is base-weighted and so runs low against total-compensation surveys, and it is used here for percentile structure rather than for levels. Corrected 2026-08-17: the Compensation section carried five SalaryDr "city averages" for pain medicine (LA ~$380k, Boston ~$370k, Miami ~$360k, Chicago ~$350k, Houston ~$340k) as evidence that coastal metros pay less. Those five figures and their report counts are published byte-for-byte identical on SalaryDr's allergy and immunology page, whose median is $270,000 lower, so they are a generic metro ladder rather than pain-medicine data — and they contradicted this page's own $630,000 median by nearly half. They have been removed rather than requoted; the directional claim now stands on practice structure and is labeled as such. ↩ ↩² ↩³ ↩⁴ ↩⁵
Base-specialty anchors (pain folded into anesthesiology) and PM&R comp. Doximity 2025 Physician Compensation Report (2024 data) — https://www.doximity.com/reports/physician-compensation-report/2025; Medscape Physician Compensation Report 2026 (2025 data) — https://www.medscape.com/p11/return-normalization-medscape-physician-compensation-report-2026a10009um. ↩ ↩² ↩³ ↩⁴
Opioid-regulation shift toward interventional work; neuromodulation reimbursement and facility-fee capture. ASIPP (American Society of Interventional Pain Physicians) — https://asipp.org/; Boston Scientific — Spinal Cord Stimulation 2026 Reimbursement Guide — https://www.bostonscientific.com/content/dam/bostonscientific/Reimbursement/Neuromodulation/pdf/SCS-Reimbursement-Guide.pdf. ↩
Overall physician burnout ~42% (2025), and the caveat that pain is folded into anesthesiology/PM&R in major surveys. AMA/Medscape 2025 via Fierce Healthcare — https://www.fiercehealthcare.com/providers/physician-burnout-falls-third-year-2025-419-american-medical-association; Healthgrades summary of Medscape 2024 — https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty. ↩
Field-specific satisfaction: 74.9% would choose pain again, recommend 8.0/10, income satisfaction 7.0/10; dissatisfaction clustering by sex, region, payer mix, and practice model. Maloney JA, D'Souza RS, Buckner Petty SA, Turkiewicz MJ, Sinha D, Patel A, Strand NH, "Job Satisfaction Among Pain Medicine Physicians in the US," Journal of Pain Research 2023;16:1867–76, PMID 37284326 — https://www.dovepress.com/job-satisfaction-among-pain-medicine-physicians-in-the-us-peer-reviewed-fulltext-article-JPR. The questionnaire was emailed in 2021 to members of the American Society of Anesthesiologists and the American Society of Pain and Neuroscience, so the respondents are a self-selected society panel rather than a sample of the field. 275 physicians answered — 81.8% anesthesiologists, 13.8% physiatrists, the rest neurology, radiology, medicine and other. The paper states that its response rate is unavailable, because the societies distributed the questionnaire and the number of physicians it reached was never known. Corrected 2026-08-17: the n and the fielding year were absent from all five places the 74.9% appeared, and the dashboard row named no society at all. Section 3a of the compensation and sourcing standard requires a society panel to carry the society's name, the year and its n in the visible sentence. Corrected 2026-08-17: the 74.9% is exact, but this page had read it as a verdict, calling the field "a solidly content" one. The paper's own conclusion is the opposite characterization: "High rates of poor job satisfaction persist among pain medicine physicians." The two measures diverge, and the page now carries both. The paper was also attributed here to "Kim et al."; its first author is Maloney. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
Punitive medical-board tactics, financial/psychological costs (~3.2-fold burnout risk among targeted physicians), and chilling effect. Kayvan Haddadan, MD, KevinMD (2026) — https://kevinmd.com/2026/03/how-punitive-board-tactics-are-harming-pain-management-physicians.html. ↩ ↩² ↩³
Opioid "pain contracts" and the adversarial doctor-patient dynamic they create. Jeffrey Singer, MD & Josh Bloom, PhD, KevinMD (2026) — https://kevinmd.com/2026/06/opioid-pain-contracts-turn-doctors-into-parole-officers.html. ↩ ↩² ↩³
Stigma toward chronic-pain and substance-use patients. David Barash, MD, Doximity Op-Med — https://opmed.doximity.com/articles/i-burdened-chronic-pain-patients-with-my-stigma. ↩ ↩² ↩³
Demographics — women ~17–21% of fellows (2009–2019) and underrepresentation of racial minorities. Shah et al., "Diversity of Pain Medicine Trainees and Faculty 2009–2019," PMID 33502490 — https://pubmed.ncbi.nlm.nih.gov/33502490/. ↩ ↩²
Synthesized/paraphrased community sentiment from r/anesthesiology, r/physiatry, r/medicine, and SDN (accessed 2026; no quotes). ↩ ↩²

Researched with AI assistance and reviewed by hand. How this site is made